Key result
Multimodal analgesia with etoricoxib, gabapentin, and epidural ropivacaine significantly reduced adverse events during early verticalization compared to systemic analgesia (25% vs 91%, p≤0.05).
Why the study?
Does multimodal analgesia with epidural ropivacaine improve pain control and early rehabilitation compared to systemic analgesia in patients after total hip arthroplasty?
RCT (n=32)
Open-label
Random number generation
No
Does multimodal analgesia with epidural ropivacaine improve pain control and early rehabilitation compared to systemic analgesia in patients after total hip arthroplasty?
Absolute Event Rate: 25% vs 91%
p-value: p=≤0.05
Multimodal analgesia incorporating epidural ropivacaine with etoricoxib and gabapentin provides effective pain relief and fewer adverse events during early mobilization after total hip arthroplasty.
Supports multimodal regimens with epidural ropivacaine for safer early mobilization after total hip arthroplasty; extends RCT evidence for multimodal over systemic analgesia.
Purpose - to assess the effect of multimodal analgesia in the early rehabilitation of patients after hip replacement. Materials and methods. A prospective single-centre randomized research, which included 32 patients. Patients of the 1st group received paracetamol, ketorolac and tramadol, the 2nd group of patients - ketorolac intravenously and the 3rd group of patients - etoricoxib and gabapentin. Patients of the 2nd and the 3rd groups underwent epidural analgesia with ropivacaine. Multimodal analgesia was carried out for 48 hours after the surgery. Assessment of pain intensity was performed by the VAS (visual analogue scale), a neuropathic pain component - on the DN4 questionnaire . Time was recorded during the first and second verticalization of patients, using the distance walkers and by fixing the distance covered with in 2 minutes. Results. The intensity of pain for more than 50 mm on VAS at movement at least once every 48 hours after the surgery was occurred among 9% of the 1st group, 22% of patients from the 2nd group and 8% of patients of the 3rd group. Number of patients with neuropathic pain component decreased from 25% to 3% (p ≤ 0.05). The first verticalization was performed 10 ± 8 hours after the surgery, the second - 21 ± 8 hours later. Two-minute walk distance was 5 ± 3 and 8 ± 4 m, respectively. It is noted more frequent adverse events in patients of the 1st group was noted compared to patients of the 2nd and the 3rd groups during first (91%, 33% and 25%, p ≤ 0.05) and the second verticalization (70%, 25% and 17%, p ≤ 0.05). Multimodal analgesia allows to proceed with the successful activation of patients after hip replacement with in the first day after the surgery. The 3rd group patients are noted with a tendency for the optimal combination of efficient and safe of analgetic therapy.
No takes yet. Share an insight, caveat, or question.
Mukutsa et al. (2012) conducted an RCT in Total hip arthroplasty (n=32). Multimodal analgesia (etoricoxib, gabapentin, and epidural ropivacaine) vs. Systemic analgesia (paracetamol, ketorolac, and tramadol) was evaluated on Adverse events during first verticalization (10 hours after surgery) (p=≤0.05). Multimodal analgesia with etoricoxib, gabapentin, and epidural ropivacaine significantly reduced adverse events during early verticalization compared to systemic analgesia (25% vs 91%, p≤0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: